Sagility Ltd.EBITDA margin 26.3%, FY27 guide raised, Chirok bought

Sagility's Q2 FY27 call, held on 22 October 2026, reported revenue of ₹20,321 million, up 22.5% in rupees and 12.2% in constant currency.

Adjusted EBITDA rose 23% to ₹5,353 million at a 26.3% margin, the highest in six quarters, and adjusted profit after tax rose 8.1% to ₹3,254 million. Management raised FY27 adjusted EBITDA margin guidance to 25% to 26% from 24% to 25% and kept low double-digit organic constant currency revenue growth guidance, but said open enrolment and AEP revenue may be about 100 basis points lower as a share of revenue than last year's 6%.

Deal ACV rose 18.2% to $40.2 million, including a payment integrity win worth over $10 million in ACV. Sagility closed the Chirok Health acquisition for $20 million upfront plus up to $12.35 million of earn-out to speed provider growth. It moved to net cash of ₹1,127 million, expects to repay remaining debt in FY27 and declared a 15 paise interim dividend.